Dingli Xu
Impact in
-
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
- Cardiac Valve Diseases and Treatments
- Heart Rate Variability and Autonomic Control
- Heart Failure Treatment and Management
- Nephrology top 2%
Papers in
-
- Cardiovascular Function and Risk Factors 23
- Heart Failure Treatment and Management 19
- Cardiac Valve Diseases and Treatments 16
- Blood Pressure and Hypertension Studies 13
- Cardiovascular Health and Disease Prevention 7
- Cardiac Fibrosis and Remodeling 7
- Co-authors
- Qingchun Zeng (66 shared papers)Hao Ren (29 shared papers)Wenyan Lai (33 shared papers)Weiyi Mai (5 shared papers)Qiong Zhan (30 shared papers)Xianzhong Meng (12 shared papers)Zuheng Liu (13 shared papers)Sheng Wang (4 shared papers)
- Journals
- Frontiers in Cardiovascular Medicine (8 papers)PLoS ONE (5 papers)Cardiovascular Research (4 papers)Clinical Cardiology (4 papers)Molecular Medicine (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Dingli Xu
154 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 141
- Cardiology and Cardiovascular Medicine 1.5k
- Nephrology 253
- Hepatology 192
- Endocrinology, Diabetes and Metabolism 393
- Pharmacology 181
Countries citing papers authored by Dingli Xu
This map shows the geographic impact of Dingli Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingli Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingli Xu more than expected).
Fields of papers citing papers by Dingli Xu
This network shows the impact of papers produced by Dingli Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingli Xu. The network helps show where Dingli Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dingli Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 236 | |
| 2 | 2013 | 173 | |
| 3 | 1995 | 133 | |
| 4 | 2009 | 128 | |
| 5 | 2017 | 128 | |
| 6 | 2013 | 109 | |
| 7 | 2017 | 96 | |
| 8 | 1998 | 89 | |
| 9 | 1998 | 88 | |
| 10 | 2014 | 86 | |
| 11 | 2017 | 85 | |
| 12 | 2018 | 81 | |
| 13 | 2021 | 80 | |
| 14 | 2014 | 80 | |
| 15 | 2019 | 79 | |
| 16 | 2015 | 76 | |
| 17 | 2013 | 75 | |
| 18 | 2012 | 73 | |
| 19 | 2023 | 72 | |
| 20 | 2020 | 71 |
About Dingli Xu
Dingli Xu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Epidemiology, having authored 161 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (23 papers), Heart Failure Treatment and Management (19 papers), Cardiac Valve Diseases and Treatments (16 papers), Blood Pressure and Hypertension Studies (13 papers), Advanced Glycation End Products research (8 papers), Cancer-related molecular mechanisms research (8 papers), Cardiovascular Health and Disease Prevention (7 papers) and Cardiac Fibrosis and Remodeling (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.5k citations), Nephrology (253 citations), Hepatology (192 citations), Endocrinology, Diabetes and Metabolism (393 citations) and Pharmacology (181 citations). Dingli Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Qingchun Zeng, Hao Ren, Wenyan Lai, Weiyi Mai, Qiong Zhan, Xianzhong Meng, Zuheng Liu, Sheng Wang, M. Ohara and Robert W. Schrier. Their work appears in journals such as Frontiers in Cardiovascular Medicine, PLoS ONE, Cardiovascular Research, Clinical Cardiology and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.